Researchers investigated the anti-fibrogenic properties and mechanisms of the conditioned medium from human umbilical cord/placenta-derived MSCs in a murine intestinal fibrosis model and human primary intestinal myofibroblasts.
[Stem Cell Research & Therapy]
